ARC Desk

Know in Plasmid DNA Manufacturing Market By Top Leading Vendors like Aldevron, Cobra Biologics Limited, Delphi Genetics, VGXI, Inc., and Others

Lehdistötiedote   •   Tammi 14, 2020 15:32 EET

The global ​Plasmid DNA Manufacturing Market Size is set to reach over US$ 300 million by 2026 and will grow at CAGR 20% during the forecast period 2019-2026. Acumen Research and Consulting, Latest Research Report on titled “Plasmid DNA Manufacturing Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 –2026”.

In the coming years, the global Plasmid DNA Manufacturing Market will continue exhibiting growth at a stable pace. The report offers a comprehensive overview of the market, covering growth drivers as well as restraints. It reveals hidden opportunities across key segments. Furthermore, the report highlights prevailing threats in the market. It is compiled with the most relevant information on the market to help companies determine their future growth strategies.

Information thus included in the report is obtained using diverse primary and secondary research methods. The report also includes interview of industry veterans. Their opinion is given due weightage in the study. In addition to this, the report includes statistics taken from various international organizations. This is done with the intent of studying the global market for the period starting from 2019 to 2026. These figures are reached using in-depth qualitative and quantitative analysis.

Competitive Landscape

In order to offer an executive level blueprint of the global Plasmid DNA Manufacturing Market, the report studies in detail the prevailing competitive landscape. The nature of competition prevailing in the global market is studied. Factors resulting into competitive rivalry among leading players are gauges as well. In this section, the report includes information obtained from various companies. Information on their product portfolio and pricing strategy is included in this section. Furthermore, the report highlights the impact of strategies adopted by these companies on this market.

Bargaining power of supplier and buyers are calculated using Porter’s five forces analysis. Furthermore, the study, helps at calculating the threat from close substitutes as well as new entrants.

Download a Free Sample Copy@ https://www.acumenresearchandconsulting.com/request-sample/1583

List of Companies

To offer a comprehensive overview, the report profiles some of the most prominent names in the industry. The market share of the global Plasmid DNA Manufacturing Market is dominated by companies like Aldevron, Cobra Biologics Limited, Delphi Genetics, VGXI, Inc., PlasmidFactory GmbH & Co. KG, LakePharma, Inc., Akron Biotech, Waisman Biomanufacturing, Richter-Helm BioLogics, Eurogentec, Kaneka Corporation, Nature Technology Corporation, Cell and Gene Therapy Catapult and among others. They are studied on the basis of their corporate policies, product portfolio, pricing strategies, recent mergers and acquisition, and various other criteria. Furthermore, recent developments witnessed in these companies in terms of recent investment, product launches, and collaborations are studied in the report in detail.

The strengths and weaknesses of the companies profiled are studied in detail. Furthermore, the report offers scope for analysing threats and opportunities existing in the market for the companies profiled.

Geography

The global Plasmid DNA Manufacturing Market can be segmented into Europe, Asia Pacific, North America, Latin America, and the Middle East and Africa.

Among key regional segments, the market is likely to witness lucrative growth opportunities in developed economies. The presence of a well-developed healthcare network is expected to support the growth of the market in these countries. Developed countries have attained the status of early adopters. While several leading companies have presence here, they are gradually shifting focus to capitalize on the prevailing opportunities in the emerging nations.

Various factors are supporting the growth witnessed across these countries. Firstly, the rise in spread of awareness is expected to bode well for the Plasmid DNA Manufacturing Market in emerging economies. Furthermore, in Asia Pacific government support towards the sector as well as investment towards expanding the healthcare and pharmaceutical industries is increasing. This is expected to drive the Plasmid DNA Manufacturing Market in Asia Pacific.

To offer an executive-level blueprint, the report calculates market share held by each of these regions. Furthermore, it identifies the leading region in this market.

Segments

The report segments the Plasmid DNA Manufacturing Market in terms of various parameters. The leading segment in each of these categories is identified in the study. Furthermore, their potential CAGR is calculated. In addition to this, the report offers insights into growth drivers and key restraints that are likely to impact the market across various segments.

Market Segmentations as below:

Market By Application

  • Gene Therapy
  • Vaccinology

Market By Disease

  • Infectious Disease
  • Cancer
  • Genetic Disorder

Market By End use

  • Research Institute
  • Biotech Companies

Market By Region

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Rest of EU
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Rest of LA
  • Middle East & Africa
    • Saudi
    • UAE
    • Rest of MEA

Key Takeaways:

  • What is the market size in 2018 and the growth rate of this research report?
  • What is the market drivers, restrains, opportunities governing the global Plasmid DNA Manufacturing Market?
  • Which is the largest and the fastest growing segments in this report?
  • Who are the key players operating in the market and their market position?
  • What is the pipeline scenario, drug pricing analysis and technological development in the market?

TABLE OF CONTENT

Chapter 1. Industry Overview of Plasmid DNA Manufacturing
1.1 Definition and Scope
1.1.1 Definition of Plasmid DNA Manufacturing
1.1.2 Market Segmentation
1.2 Summary
1.2.1 Market Snapshot
1.3 Global Plasmid DNA Manufacturing Market By Application
1.3.1 Global Plasmid DNA Manufacturing Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.3.2 Gene Therapy
1.3.3 Vaccinology
1.4 Global Plasmid DNA Manufacturing Market By Disease
1.4.1 Global Plasmid DNA Manufacturing Market Revenue and Growth Rate Comparison By Disease (2015-2026)
1.4.2 Infectious Disease
1.4.3 Genetic Disorders
1.4.4 Cancer
1.5 Global Plasmid DNA Manufacturing Market By End Use
1.5.1 Global Plasmid DNA Manufacturing Market Revenue and Growth Rate Comparison By End Use (2015-2026)
1.5.2 Research Institutes
1.5.3 Biotech Companies
1.6 Global Plasmid DNA Manufacturing Market by Regions
1.6.1 Global Plasmid DNA Manufacturing Market Size and Growth Rate Comparison by Regions (2015-2026)
1.6.2 North America Plasmid DNA Manufacturing Market Revenue And Growth Rate (2015-2026)
1.6.3 Europe Plasmid DNA Manufacturing Market Revenue And Growth Rate (2015-2026)
1.6.4 Asia-Pacific Plasmid DNA Manufacturing Market Revenue And Growth Rate (2015-2026)
1.6.5 Latin America Plasmid DNA Manufacturing Market Revenue And Growth Rate (2015-2026)
1.6.6 Middle East & Africa Plasmid DNA Manufacturing Market Revenue And Growth Rate (2015-2026)

Chapter 2. Market Dynamics and Competition Analysis
2.1 Market Drivers
2.2 Restraints and Challenges
2.3 Growth Opportunities
2.4 Porter’s Five Forces Analysis
2.4.1 Low Bargaining Power of Suppliers
2.4.2 Medium Bargaining Power of Buyers
2.4.3 High Threat of Substitute
2.4.4 Low Threat of New Entrants
2.4.5 High Degree of Competition
2.5 Value Chain Analysis
2.6 Cost structure Analysis
2.6.1 Raw Material and Suppliers
2.6.2 Proportion of Manufacturing Cost Structure
2.6.2.1 Raw Material
2.6.2.2 Labor Cost
2.6.2.3 Manufacturing Expense
2.7 Regulatory Compliance
2.8 Competitive Landscape, 2018
2.8.1 Player Positioning Analysis
2.8.2 Key Strategies Adopted By Leading Players

Chapter 3. Manufacturing Plant Analysis
3.1 Revenue and Commercial Date of Global Plasmid DNA Manufacturing Major Manufacturers in 2018
3.2 Manufacturing Plants Distribution of Global Plasmid DNA Manufacturing Major Manufacturers in 2018

Chapter 4. Plasmid DNA Manufacturing Market By Application
4.1 Global Plasmid DNA Manufacturing Revenue by Application
4.2 Gene Therapy
4.2.1 Market Revenue and Growth Rate, 2015 - 2026 (US$ Million)
4.2.2 Market Revenue and Forecast, By Region, 2015 - 2026 (US$ Million)
4.3 Vaccinology
4.3.1 Market Revenue and Growth Rate, 2015 - 2026 (US$ Million)
4.3.2 Market Revenue and Forecast, By Region, 2015 - 2026 (US$ Million)

Chapter 5. Plasmid DNA Manufacturing Market By Disease
5.1 Global Plasmid DNA Manufacturing Revenue by Disease
5.2 Infectious Disease
5.2.1 Market Revenue and Growth Rate, 2015 - 2026 (US$Mn)
5.2.2 Market Revenue and Forecast, By Region, 2015 - 2026 (US$Mn)
5.3 Genetic Disorders
5.3.1 Market Revenue and Growth Rate, 2015 - 2026 (US$Mn)
5.3.2 Market Revenue and Forecast, By Region, 2015 - 2026 (US$Mn)
5.4 Cancer
5.4.1 Market Revenue and Growth Rate, 2015 - 2026 (US$Mn)
5.4.2 Market Revenue and Forecast, By Region, 2015 - 2026 (US$Mn)

Chapter 6. Plasmid DNA Manufacturing Market By End Use
6.1 Global Plasmid DNA Manufacturing Revenue by End Use
6.2 Research Institutes
6.2.1 Market Revenue and Growth Rate, 2015 - 2026 (US$Mn)
6.2.2 Market Revenue and Forecast, By Region, 2015 - 2026 (US$Mn)
6.3 Biotech Companies
6.3.1 Market Revenue and Growth Rate, 2015 - 2026 (US$Mn)
6.3.2 Market Revenue and Forecast, By Region, 2015 - 2026 (US$Mn)

Chapter 7. North America Plasmid DNA Manufacturing Market By Country
7.1 North America Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 - 2026 (US$ Million)
7.2 North America Plasmid DNA Manufacturing Market Revenue Share, by Country, 2018 (%)
7.3 U.S.
7.3.1 U.S. Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
7.3.2 U.S. Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
7.3.3 U.S. Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
7.4 Canada
7.4.1 Canada Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
7.4.2 Canada Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
7.4.3 Canada Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)

Chapter 8. Europe Plasmid DNA Manufacturing Market By Country (8)
8.1 Europe Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 - 2026 (US$ Million)
8.2 Europe Plasmid DNA Manufacturing Market Revenue Share, By Country, 2018 (%)
8.3 UK
8.3.1 UK Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
8.3.2 UK Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
8.3.3 UK Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
8.4 Germany
8.4.1 Germany Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
8.4.2 Germany Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
8.4.3 Germany Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
8.5 France
8.5.1 France Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
8.5.2 France Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
8.5.3 France Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
8.6 Spain
8.6.1 Spain Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
8.6.2 Spain Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
8.6.3 Spain Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
8.7 Italy
8.7.1 Italy Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
8.7.2 Italy Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
8.7.3 Italy Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
8.8 Rest of Europe
8.8.1 Rest of Europe Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
8.8.2 Rest of Europe Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
8.8.3 Rest of Europe Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)

Chapter 9. Asia-Pacific Plasmid DNA Manufacturing Market By Country
9.1 Asia-Pacific Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 - 2026 (US$ Million)
9.2 Asia-Pacific Plasmid DNA Manufacturing Market Revenue Share Comparison, By Country, 2015 & 2026 (%)
9.3 China
9.3.1 China Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
9.3.2 China Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
9.3.3 China Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
9.4 Japan
9.4.1 Japan Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
9.4.2 Japan Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
9.4.3 Japan Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
9.5 India
9.5.1 India Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
9.5.2 India Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
9.5.3 India Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
9.6 Australia
9.6.1 Australia Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
9.6.2 Australia Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
9.6.3 Australia Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
9.7 South Korea
9.7.1 South Korea Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
9.7.2 South Korea Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
9.7.3 South Korea Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
9.8 Rest of Asia-Pacific
9.8.1 Rest of Asia-Pacific Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
9.8.2 Rest of Asia-Pacific Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
9.8.3 Rest of Asia-Pacific Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)

Chapter 10. Latin America Plasmid DNA Manufacturing Market By Country
10.1 Latin America Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 - 2026 (US$ Million)
10.2 Latin America Plasmid DNA Manufacturing Market Revenue Share, by Country, 2018 (%)
10.3 Brazil
10.3.1 Brazil Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
10.3.2 Brazil Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
10.3.3 Brazil Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
10.4 Mexico
10.4.1 Mexico Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
10.4.2 Mexico Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
10.4.3 Mexico Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
10.5 Rest of Latin America
10.5.1 Rest of Latin America Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
10.5.2 Rest of Latin America Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
10.5.3 Rest of Latin America Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)

Chapter 11. Middle East & Africa Plasmid DNA Manufacturing Market By Country
11.1 Middle East & Africa Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 - 2026 (US$ Million)
11.2 Middle East & Africa Plasmid DNA Manufacturing Market Revenue Share Comparison, By Countries, 2018 (%)
11.3 Saudi Arabia
11.3.1 Saudi Arabia Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
11.3.2 Saudi Arabia Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
11.3.3 Saudi Arabia Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
11.4 UAE
11.4.1 UAE Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
11.4.2 UAE Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
11.4.3 UAE Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
11.5 Rest of Middle East & Africa
11.5.1 Rest of Middle East & Africa Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
11.5.2 Rest of Middle East & Africa Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
11.5.3 Rest of Middle East & Africa Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)

Chapter 12. Major Manufacturers Analysis of Plasmid DNA
12.1 Cobra Biologics Limited
12.1.1 Business Overview
12.1.2 Company Profile
12.1.3 Cobra Biologics Limited 2018 Financial Analysis
12.1.4 Cobra Biologics Limited 2018 Plasmid DNA Business Region Distribution Analysis
12.1.5 Product Segment
12.1.6 Marketing Strategy and Recent Development
12.2 Novasep Inc.
12.2.1 Business Overview
12.2.2 Company Profile
12.2.3 Novasep Inc. 2018 Financial Analysis
12.2.4 Novasep Inc. 2018 Plasmid DNA Business Region Distribution Analysis
12.2.5 Product Segment
12.2.6 Marketing Strategy and Recent Development
12.3 Spark Therapeutics, Inc.
12.3.1 Business Overview
12.3.2 Company Profile
12.3.3 Spark Therapeutics, Inc. 2018 Financial Analysis
12.3.4 Spark Therapeutics, Inc. 2018 Plasmid DNA Business Region Distribution Analysis
12.3.5 Product Segment
12.3.6 Marketing Strategy and Recent Development
12.4 FUJIFILM Diosynth Biotechnologies Inc.
12.4.1 Business Overview
12.4.2 Company Profile
12.4.3 FUJIFILM Diosynth Biotechnologies Inc. 2018 Financial Analysis
12.4.4 FUJIFILM Diosynth Biotechnologies Inc. 2018 Plasmid DNA Business Region Distribution Analysis
12.4.5 Product Segment
12.4.6 Marketing Strategy and Recent Development
12.5 Cell and Gene Therapy Catapult
12.5.1 Business Overview
12.5.2 Company Profile
12.5.3 Cell and Gene Therapy Catapult 2018 Plasmid DNA Sales, Ex-factory Price, Revenue, Gross Margin Analysis
12.5.4 Cell and Gene Therapy Catapult 2018 Plasmid DNA Business Region Distribution Analysis
12.5.5 Product Segment
12.5.6 Marketing Strategy and Recent Development
12.6 Kaneka Eurogentec S.A (KANEKA)
12.6.1 Business Overview
12.6.2 Company Profile
12.6.3 Kaneka Eurogentec S.A 2018 Plasmid DNA Sales, Ex-factory Price, Revenue, Gross Margin Analysis
12.6.4 Kaneka Eurogentec S.A 2018 Plasmid DNA Business Region Distribution Analysis
12.6.5 Product Segment
12.6.6 Marketing Strategy and Recent Development
12.7 UniQure N.V.
12.7.1 Business Overview
12.7.2 Company Profile
12.7.3 uniQure N.V. Financial Analysis, 2019
12.7.4 uniQure N.V Plasmid DNA Business Region Distribution Analysis, 2019
12.7.5 Product Segment
12.7.6 Marketing Strategy and Recent Development
12.8 Lonza
12.8.1 Business Overview
12.8.2 Company Profile
12.8.3 Lonza Financial Analysis, 2018
12.8.4 Lonza Plasmid DNA Business Region Distribution Analysis, 2018
12.8.5 Product Segment
12.8.6 Marketing Strategy and Recent Development
12.9 Merk KgaA
12.9.1 Business Overview
12.9.2 Company Profile
12.9.3 Merk KgaA Financial Analysis, 2018
12.9.4 Merk KgaA Plasmid DNA Business Region Distribution Analysis, 2018
12.9.5 Product Segment
12.9.6 Marketing Strategy and Recent Development

Chapter 13. Research Approach
13.1 Methodology
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources

The report is readily available and can be dispatched immediately after payment confirmation.

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1583

Contact Us:

Acumen Research and Consulting

Phone: +1 407 915 4157

Email: sales@acumenresearchandconsulting.com

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.